Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted.DXVX is taking...

AI, Tech, and Thriving in Online Business
Business Partnership Disputes on the Rise Across Arizona, Says Enara Law
Media87 Named 2026’s Top Digital Marketing Agency and Local
IS YOUR BUSINESS VISITOR READY?
6 Types of Digital Marketing Materials Worth Mastering (2026)